587 related articles for article (PubMed ID: 26335664)
21. Liquid biopsies.
Lianidou E; Pantel K
Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
[TBL] [Abstract][Full Text] [Related]
22. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
[TBL] [Abstract][Full Text] [Related]
23. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
[TBL] [Abstract][Full Text] [Related]
24. Research progress on liquid biopsy in oncology and its clinical applications.
Wang C; Li YM; Fang XD
Yi Chuan; 2017 Mar; 39(3):220-231. PubMed ID: 28420618
[TBL] [Abstract][Full Text] [Related]
25. Patient monitoring through liquid biopsies using circulating tumor DNA.
Ulz P; Heitzer E; Geigl JB; Speicher MR
Int J Cancer; 2017 Sep; 141(5):887-896. PubMed ID: 28470712
[TBL] [Abstract][Full Text] [Related]
26. Liquid Biopsies for Assessing Metastatic Melanoma Progression.
Huynh K; Hoon DS
Crit Rev Oncog; 2016; 21(1-2):141-54. PubMed ID: 27481010
[TBL] [Abstract][Full Text] [Related]
27. Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients.
Mondelo-Macía P; Rodríguez-López C; Valiña L; Aguín S; León-Mateos L; García-González J; Abalo A; Rapado-González O; Suárez-Cunqueiro M; Díaz-Lagares A; Curiel T; Calabuig-Fariñas S; Azkárate A; Obrador-Hevia A; Abdulkader I; Muinelo-Romay L; Diaz-Peña R; López-López R
Cells; 2020 Feb; 9(2):. PubMed ID: 32102486
[TBL] [Abstract][Full Text] [Related]
28. Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.
Alix-Panabières C; Pantel K
Expert Rev Mol Diagn; 2015; 15(11):1411-7. PubMed ID: 26390240
[TBL] [Abstract][Full Text] [Related]
29. Circulating Tumor Cells as Cancer Biomarkers in the Clinic.
Chinen LTD; Abdallah EA; Braun AC; Flores BCTCP; Corassa M; Sanches SM; Fanelli MF
Adv Exp Med Biol; 2017; 994():1-41. PubMed ID: 28560666
[TBL] [Abstract][Full Text] [Related]
30. Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.
Esposito A; Criscitiello C; Locatelli M; Milano M; Curigliano G
Pharmacol Ther; 2016 Jan; 157():120-4. PubMed ID: 26615782
[TBL] [Abstract][Full Text] [Related]
31. The current status of the clinical utility of liquid biopsies in cancer.
Snow A; Chen D; Lang JE
Expert Rev Mol Diagn; 2019 Nov; 19(11):1031-1041. PubMed ID: 31482746
[No Abstract] [Full Text] [Related]
32. Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
Miyamoto DT; Lee RJ
Urol Oncol; 2016 Nov; 34(11):490-501. PubMed ID: 27771279
[TBL] [Abstract][Full Text] [Related]
33. Emerging circulating biomarkers in glioblastoma: promises and challenges.
Touat M; Duran-Peña A; Alentorn A; Lacroix L; Massard C; Idbaih A
Expert Rev Mol Diagn; 2015; 15(10):1311-23. PubMed ID: 26394701
[TBL] [Abstract][Full Text] [Related]
34. The Introduction and Clinical Application of Cell-Free Tumor DNA.
Li J; Liu R; Huang C; Chen S; Xu M
Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
[TBL] [Abstract][Full Text] [Related]
35. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
Fici P
Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
[TBL] [Abstract][Full Text] [Related]
36. The clinical role of circulating free tumor DNA in gastrointestinal malignancy.
Howell JA; Khan SA; Knapp S; Thursz MR; Sharma R
Transl Res; 2017 May; 183():137-154. PubMed ID: 28056336
[TBL] [Abstract][Full Text] [Related]
37. Circulating Biomarkers for Prediction of Treatment Response.
Cappelletti V; Appierto V; Tiberio P; Fina E; Callari M; Daidone MG
J Natl Cancer Inst Monogr; 2015 May; 2015(51):60-3. PubMed ID: 26063889
[TBL] [Abstract][Full Text] [Related]
38. Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.
Zhou J; Chang L; Guan Y; Yang L; Xia X; Cui L; Yi X; Lin G
PLoS One; 2016; 11(7):e0159708. PubMed ID: 27459628
[TBL] [Abstract][Full Text] [Related]
39. Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation.
Lowes LE; Bratman SV; Dittamore R; Done S; Kelley SO; Mai S; Morin RD; Wyatt AW; Allan AL
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618023
[TBL] [Abstract][Full Text] [Related]
40. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer.
Gao Y; Zhu Y; Yuan Z
Int J Med Sci; 2016; 13(12):902-913. PubMed ID: 27994495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
